«Arterium» Corporation among the most socially responsible companies of Ukraine
15.03.2012
The fifth rating of openness and consistency of Ukrainian companies in corporate social responsibility (CSR) is published. According to the results of the analysis of the magazine "Gvardiya» «Arterium» Corporation took 14th place with the final score 62.19 form possible 100.
Results of rating in CSR-2012 are based on questionnaires completed by participating companies, public non-financial reports, and assessments of independent Ukrainian experts. Evaluation methodology involves using an integrated method and system analysis levels of disclosure, as well as the activities of companies in the field of CSR.
Rating of the most successful TOP managers of Ukraine 2011 - results are published
12.03.2012
All-Ukrainian rating magazine “Gvardiya” published an annual list of the most successful TOP managers of Ukraine for the year 2011.
Denis Gartsylov, Chief Executive Officer of “Arterium”Corporation, takes 27 place in the general rating with 83.6 points out of a maximum of 100 and 2nd place in the pharmaceutical industry.
Get free from the stress "mask" - advertising TV campaign of "Glicised"
05.03.2012
On the 20th of February an advertising campaign of anti-stress medication Glicised started on television. 20-second clip is being broadcasted on channels 1 +1, 2 +2, Tet, Ukraine, 5-th channel, Tonis. The advertising campaign will last during winter and spring, 2012.
MEPENAM production has been restarted
23.01.2012
We are pleased to inform you that the drug Mepenam entered the list to certificate of compliance to Good Manufacturing Practice issued by the State Service of Ukraine for pharmaceutical drugs, and given for the injectable cephalosporines area of JSC "Kyivmedpreparat". We would like to recall the fact that, confirming compliance with the production conditions of manufactured medicines to international standards of pharmaceutical industry in 2011, the Corporation received national certificates of Good Manufacturing Practice for several areas.
Inspiron®, tablets - a new drug in Arterium Corporation portfolio!
12.05.2011
Kievmedpreparat OJSC, which is the part of Arterium Corporation, has released the first series of the new drug Inspiron®, tablets, film-coated, 80 mg.
Arterium Corporation has announced its results for 2010
15.04.2011
Arterium Corporation, a leading Ukrainian pharmaceutical company, has announced its results for 2010.
2010 was a year of strengthening market position of Arterium Corporation in all key markets of its activities: Corporation income increased by 29% to $ 852 mln UAH (2009: 662 mlnUAH), growth in Ukraine was 25%, export sales grew by 41%.
The first series of Floxium, solution for infusion were released
16.12.2010
Kievmedpreparat OJSC, which is part of Arterium Corporation, released a new product - Floxium, infusion solution 5mh/ml, 100 ml.
A new dosage of Casark®, pills - 16 mg and 32 mg was registered
24.11.2010
Kievmedpreparat OJSC, which is part of Arterium Corporation, released the first series of new dosage of Casark®, tablets 16 mg №30 and Kasark®, tablets 32 mg №30.
Mepenam – a new drug from OJSC Kievmedpreparat
13.09.2010
Kievmedpreparat OJSC, which is part of Arterium Corporation, released the first series of new drug Mepenam, powder for injection solution, in 1.0 g vials.
